LCI : Analysis & Opinions

  1. Lannett 1Q Loss 80c/Shr vs Net 89c Last Year (LCI)

    November 5, 2016
    Lannett reported a 1Q loss and revised its full-year sales projections downward.
  2. Drug Makers May Face DOJ Lawsuit (LCI, ENDP)

    November 4, 2016
    DOJ investigates more than a dozen generic drug companies over alleged price fixation for two-dozen drugs, based on two year ...
  3. Breaking Down XLV: 3 Components That Are Most Attractive

    May 9, 2016
    Discover three attractive component stocks in the Health Care Select Sector SPDR ETF, and learn which company may be the ...
  4. Why Lannett Cut Its Guidance for Fiscal 2016

    March 24, 2016
    LannettĀ (NYSE: LCI) has revised downward its guidance for the current fiscal year. Among other line item projections, the ...
  5. 3 Companies With High Working Capital (GT, GILD)

    February 18, 2016
    Learn about working capital, its importance in determining corporate financial stability and three stocks with high working ...
  6. The S&P 500's 5 Fastest-Growing Companies

    September 10, 2015
    These are the five fastest growing companies in the S&P 500. Should they be on your watch list?
  7. Lannett Makes a $1.2 Billion Acqusition (LCI)

    September 3, 2015
    Generic drugs producer Lannett (NYSE: LCI) is adding a new asset to its portfolio. The company announced this week that ...
  8. Are These 2015's 10 Best Generic Pharma Stocks?

    June 3, 2015
    These 10 generic generic pharma stocks present a lot of upside potential for the second half of 2015. Here's why.
Trading Center